Urolithin A and Mitochondrial Recycling

A closer look at mitophagy, muscle trials and the limits of the evidence.

Mitochondria are often described as the power plants of a cell. Less attention goes to the maintenance work around them: identifying damage, replacing components and removing structures that no longer function well. Urolithin A has become a subject of longevity research because of its connection to that maintenance process.

The human evidence is interesting, but it does not support every claim that has grown around the ingredient. Several trials report changes in muscle tests or molecular measurements. Important primary outcomes have also been negative, and the studies have generally been small and short. Both parts belong in the story. [1–7]

What Urolithin A Is and Where It Comes From

Urolithin A, abbreviated UA, is a metabolite that certain gut microbes can produce from dietary ellagitannins and ellagic acid. Foods such as pomegranates, walnuts and some berries provide these precursor compounds. Eating those foods does not deliver a standardized supplement dose of UA. Conversion depends in part on the person's gut microbial community, and people differ in their capacity to produce it. [1, 4]

Supplement studies generally administer UA itself. That bypasses the need to produce the same quantity from food precursors, but it does not make food and supplementation equivalent. A pomegranate study and a purified-UA study answer different questions. Nor does variation in microbial production establish that a low producer needs a supplement. [1, 2]

What Mitophagy Means

Mitophagy is a selective form of autophagy through which cells remove mitochondria. In this process, cellular machinery identifies mitochondria for disposal and routes material toward lysosomal degradation. It is part of mitochondrial quality control, alongside other processes such as repair, division, fusion and the generation of new mitochondrial components. [1]

In a foundational 2016 study, UA induced mitophagy in experimental systems, extended lifespan in the worm C. elegans and improved aspects of muscle function in rodents. These were preclinical findings. They did not demonstrate human lifespan extension or show that a person can reverse aging by taking UA. [1]

Measuring the mechanism in people is more difficult than the housekeeping metaphor makes it sound. More of a protein associated with mitophagy is not the same as directly measuring the rate at which damaged mitochondria are removed. A molecular signature can support a hypothesis without proving the full sequence of events in living human muscle. [2, 4]

What the Human Trials Found

The First Human Studies Focused on Tolerability and Biomarkers

A first-in-human trial published in Nature Metabolism in 2019 assessed single doses and repeated dosing over four weeks in healthy, sedentary older adults. Safety was the primary focus. At 500 and 1,000 mg daily, researchers also observed changes in plasma acylcarnitines and skeletal muscle mitochondrial gene expression. [2]

Those results showed that oral UA was bioavailable and could affect measured biological pathways. They did not establish improvements in everyday mobility or long-term health. [2]

The Older Adult Muscle Trial

In a 2022 JAMA Network Open trial, 66 adults aged 65–90 received 1,000 mg of UA daily or placebo for four months. The primary outcomes were six-minute walking distance and maximal ATP production in hand muscle. Neither showed a statistically significant advantage for UA over placebo. [3]

Secondary endurance tests in hand and leg muscles favored UA at two months. These tests measured repeated contractions until fatigue; they were not measures of overall strength or the ability to manage every daily activity. The participants were predominantly women and all were White, which limits generalization; the study also involved investigators with company ties. [3]

What the Middle-Aged Adult Trial Adds

The 2022 ATLAS trial randomized 88 adults aged 40–64 to placebo or 500 or 1,000 mg of UA daily for four months. Certain hamstring strength measures improved relative to placebo, but peak power output, the prespecified primary outcome, did not. [4]

The frequently repeated "12% stronger" figure came from a particular hamstring measurement in the 500-mg group. It was not a universal gain in whole-body strength. Muscle biopsy analyses found changes in proteins associated with mitochondrial pathways, but did not directly quantify mitophagy flux. ATLAS was funded by Amazentis, with several authors affiliated with the company. [4]

Immune Cell Research Is a Different Kind of Evidence

A Nature Aging trial published in October 2025 studied 50 healthy adults over four weeks using 1,000 mg of UA daily or placebo. It reported changes in some T-cell populations and immune-cell metabolic measurements. These are laboratory and cellular findings, not proof that participants developed fewer infections or experienced clinically reversed immune aging. [5, 6]

What the Pooled Evidence Says

A July 2026 systematic review identified five randomized trials involving 236 participants. Only the six-minute walk test could be quantitatively pooled, using two trials. The pooled estimate favored UA by about 17 meters, but its 95% confidence interval crossed zero. The authors rated that evidence as low certainty. [7]

What This Means When Reading a Label

The doses above describe research protocols, not a recommended regimen. UA research is most useful when we keep the questions separate: Does it enter the circulation? Does it change a pathway? Does it change performance? Does it improve long-term health? A positive answer to one does not settle the others. [2–7]

References

1. Ryu D et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature Medicine. 2016;22(8). doi.org/10.1038/nm.4132
2. Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. 2019;1(6). doi.org/10.1038/s42255-019-0073-4
3. Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults. JAMA Network Open. 2022;5(1). PMC
4. Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022;3(5). PMC
5. Denk D et al. Effect of the mitophagy inducer urolithin A on age-related immune decline. Nature Aging. 2025;5(11). doi.org/10.1038/s43587-025-00996-x
6. Denk D et al. Author Correction. Nature Aging. 2026;6(2).
7. Dao T et al. Effects of Urolithin A supplementation on muscle health outcomes in humans from randomized controlled trials. Frontiers in Nutrition. 2026;13.